SURVIVAL AND TREATMENT PATTERNS IN PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA (MM) IN A REAL-WORLD SETTING

被引：0

作者：

Hajek, R. ^{[1
,2
]}

Jarkovsky, J. ^{[3
,4
]}

Maisnar, V. ^{[5
,6
]}

Pour, L. ^{[7
,8
]}

Spicka, I. ^{[9
,10
]}

Minarik, J. ^{[11
,12
]}

Gregora, E. ^{[13
]}

Kessler, P. ^{[14
]}

Sykora, M. ^{[15
]}

Frankova, H. ^{[16
]}

Adamova, D. ^{[17
]}

Wrobel, M. ^{[18
]}

Mikula, P. ^{[19
]}

Campioni, M. ^{[20
]}

DeCosta, L. ^{[21
]}

Treur, M. ^{[22
]}

Gonzalez-McQuire, S. ^{[20
]}

Bouwmeester, W. ^{[22
]}

机构：

[1] Univ Ostrava, Fac Med, Ostrava, Czech Republic

[2] Univ Hosp Ostrava, Dept Hematooncol, Ostrava, Czech Republic

[3] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic

[4] Masaryk Univ, Fac Sci, Brno, Czech Republic

[5] Charles Univ Prague, Dept Internal Med Hematol 4, Fac Hosp, Hradec Kralove, Czech Republic

[6] Charles Univ Prague, Fac Med, Hradec Kralove, Czech Republic

[7] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic

[8] Masaryk Univ, Fac Med, Brno, Czech Republic

[9] Gen Univ Hosp, Internal Clin 1, Clin Hematol, Hradec Kralove, Czech Republic

[10] Charles Univ Prague, Fac Med 1, Hradec Kralove, Czech Republic

[11] Univ Hosp Olomouc, Dept Hematooncol, Olomouc, Czech Republic

[12] Palacky Univ Olomouc, Fac Med & Dent, Olomouc, Czech Republic

[13] Univ Hosp Kralovske Vinohrady, Dept Internal Med & Hematol, Prague, Czech Republic

[14] Hosp Pelhrimov, Dept Hematol & Transfus Med, Pelhrimov, Czech Republic

[15] Hosp Ceske Budejovice, Dept Clin Hematol, Ceske Budejovice, Czech Republic

[16] Gen Hosp Liberec, Dept Hematol, Liberec, Czech Republic

[17] Silesian Hosp Opava, Dept Clin Hematol, Opava, Czech Republic

[18] Complex Oncol Ctr, Novy Jicin, Czech Republic

[19] Hosp Havirov, Dept Clin Haematol, Havirov, Czech Republic

[20] Amgen Europe GmbH, Zug, Switzerland

[21] Amgen Ltd, Uxbridge, Middx, England

[22] Pharmerit Int, Rotterdam, Netherlands

来源：

HAEMATOLOGICA | 2016年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

E1280

引用

页码：529 / 529

页数：1

共 50 条

[21] Real-World Treatment Patterns and Outcomes of Triple-Exposed Multiple Myeloma (MM) Patients Treated in Community Oncology Practices in the US
Smith, Robert
Xue, Mei
Dorrow, Natalie
Varughese, Prateesh
Hogea, Cosmina
Buckingham, Trudy
Sansbury, Leah
Ferrante, Shannon
Maiese, Eric M.
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S419 - S420
[22] Real-World Treatment Patterns from the HUMANS Study in Multiple Myeloma in Denmark
Abildgaard, Niels
Waage, Anders
Hansson, Markus
Anttila, Pekka
Szilcz, Mate
Ma, Yuanjun
Rubin, Katrine Hass
von Arx, Lill-Brith
Orstavik, Sigurd
Bent-Ennakhil, Nawal
Freilich, Jonatan
Gavini, Francois
Green, Anders
[J]. BLOOD, 2019, 134
[23] Real-World Disparities in Daratumumab Utilization for Patients with Relapsed or Refractory Multiple Myeloma (MM)
Maignan, Kathleen
Backenroth, Daniel
McQuarrie, Neil A.
Lipitz, Nicole G.
Williams, Erin R.
Carson, Kenneth R.
[J]. BLOOD, 2018, 132
[24] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
Harvey, R. Donald
Cong, Ze
Werther, Winifred
Lethen, Jan L.
Lonial, Sagar
[J]. BLOOD, 2014, 124 (21)
[25] Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world setting
Alegre, Adrian
Gironella, Mercedes
Escalante, Fernando
Bergua, Juan M.
Martinez-Chamorro, Carmen
Lopez, Aurelio
Gonzalez, Esther
Barez, Abelardo
Somolinos, Nieves
Persona, Ernesto P.
Cabrera, Alexia S.
Soler, Alfons
Rodriguez, Belen I.
Lopez, Joaquin M.
Gonzalez, Yolanda
Gimenez, Veronica C.
Sampol, Antonia
Munoz, Carolina
Vilanova, David
Duran, Marta
de Larrea, Carlos Fernandez
[J]. HEMASPHERE, 2024, 8 (07):
[26] Real-World Trends in Treatment Use, Healthcare Costs, and Overall Survival Among Patients with Multiple Myeloma
Fonseca, Rafael
Abouzaid, Safiya
Bonafede, Machaon
Cai, Qian
Parikh, Kejal
Cosler, Leon
Richardson, Paul
[J]. BLOOD, 2016, 128 (22)
[27] Real-world evidence for carfilzomib dosing intensity on overall survival and treatment progression in multiple myeloma patients
Raje, Noopur
Medhekar, Rohan
Panjabi, Sumeet
Hines, Dionne M.
Wang, Xin
Iskander, Karim
Welliver, Tim
Wade, Rolin L.
Ailawadhi, Sikander
[J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (05) : 1130 - 1139
[28] Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
María José Cejalvo
Gabriela Bustamante
Esther González
Judith Vázquez-Álvarez
Ricarda García
Ángel Ramírez-Payer
Ernesto Pérez-Persona
Eugenia Abella
Sebastián Garzón
Antoni García
Isidro Jarque
Marta Sonia González
Antonia Sampol
Cristina Motlló
Josep María Martí
Magdalena Alcalá
Rafael Duro
Yolanda González
José Luis Sastre
Josep Sarrà
Giselle Lostaunau
Rocío López
Javier de la Rubia
[J]. Annals of Hematology, 2021, 100 : 1769 - 1778
[29] Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
Cejalvo, Maria Jose
Bustamante, Gabriela
Gonzalez, Esther
Vazquez-Alvarez, Judith
Garcia, Ricarda
Ramirez-Payer, Angel
Perez-Persona, Ernesto
Abella, Eugenia
Garzon, Sebastian
Garcia, Antoni
Jarque, Isidro
Gonzalez, Marta Sonia
Sampol, Antonia
Motllo, Cristina
Marti, Josep Maria
Alcala, Magdalena
Duro, Rafael
Gonzalez, Yolanda
Sastre, Jose Luis
Sarra, Josep
Lostaunau, Giselle
Lopez, Rocio
de la Rubia, Javier
[J]. ANNALS OF HEMATOLOGY, 2021, 100 (07) : 1769 - 1778
[30] Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in Europe
Martinez-Lopez, Joaquin
Bailey, Abigail
Lambert, Annabel
Luke, Emily
Ribbands, Amanda
Erler-Yates, Nichola
Valluri, Satish
Haefliger, Benjamin
Gay, Francesa
[J]. FUTURE ONCOLOGY, 2023, 19 (31) : 2103 - 2121

← 1 2 3 4 5 →